Revance Therapeutics shares owned by D. E. Shaw & Co
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by D. E. Shaw & Co
from 13F filings
Historical chart of D. E. Shaw & Co investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by D. E. Shaw & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by D. E. Shaw & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $10M | 2.0M | 5.19 |
| 2024-06-30 | $355k | 138k | 2.57 |
| 2024-03-31 | $1.6M | 328k | 4.92 |
| 2023-12-31 | $3.9M | 442k | 8.79 |
| 2023-09-30 | $9.3M | 812k | 11.47 |
| 2023-06-30 | $51M | 2.0M | 25.31 |
| 2023-03-31 | $74M | 2.3M | 32.21 |
| 2022-12-31 | $25M | 1.3M | 18.46 |
| 2022-09-30 | $40M | 1.5M | 27.00 |
| 2022-06-30 | $11M | 818k | 13.82 |
| 2022-03-31 | $17M | 846k | 19.50 |
| 2021-12-31 | $8.5M | 524k | 16.32 |
| 2021-09-30 | $257k | 9.2k | 27.81 |
| 2021-06-30 | $1.4M | 48k | 29.63 |
| 2020-12-31 | $253k | 8.9k | 28.32 |
| 2020-09-30 | $794k | 32k | 25.14 |
| 2020-06-30 | $271k | 11k | 24.39 |
| 2020-03-31 | $182k | 12k | 14.80 |
| 2019-06-30 | $281k | 22k | 12.96 |
| 2019-03-31 | $469k | 30k | 15.78 |
| 2018-12-31 | $2.0M | 101k | 20.13 |
| 2018-09-30 | $1.6M | 65k | 24.85 |
| 2018-06-30 | $2.1M | 78k | 27.45 |
| 2018-03-31 | $286k | 9.3k | 30.79 |
| 2017-12-31 | $1.6M | 44k | 35.75 |
| 2016-12-31 | $222k | 11k | 20.71 |
| 2016-03-31 | $954k | 55k | 17.47 |
| 2015-12-31 | $5.5M | 160k | 34.16 |
| 2015-09-30 | $756k | 25k | 29.76 |
| 2015-06-30 | $1.3M | 42k | 31.98 |